Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

NCT01983449 is registered in ClinicalTrials.gov with Mercator MedSystems, Inc. as lead sponsor.

NCT NCT01983449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01983449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Lead sponsor
Mercator MedSystems, Inc.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
January 31, 2018
Enrollment
285 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial diseases